APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cancer Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cancer Vaccines Industry Growth and Trends Forecast to 2032

Report ID 173974440122 December 202590 pages

Choose your research edition.

Industry ResearchCancer Vaccines Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Vaccines Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Cancer Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Vaccines Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cancer Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Vaccines include Merck, Pfizer, Glaxosmithkline, Serum Institute of India, Sanpower Group, Sanofi Pasteur, CSL Limited and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cancer Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cancer Vaccines market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cancer Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cancer Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cancer Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cancer Vaccines Market by Company

Merck

Pfizer

Glaxosmithkline

Serum Institute of India

Sanpower Group

Sanofi Pasteur

CSL Limited

Astellas Pharma

Cancer Vaccines Segment by Type

Preventive Cancer Vaccines

Therapeutic Cancer Vaccines

Cancer Vaccines Segment by Application

Cervical Cancer

Prostate Cancer

Others

Cancer Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cancer Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cancer Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Preventive Cancer Vaccines Table 2. Major Company of Therapeutic Cancer Vaccines Table 3. Global Cancer Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 5. Global Cancer Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cancer Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Cancer Vaccines Price by Type (2021-2026) & (US$/unit) Table 9. Global Cancer Vaccines Sales by Type (2027-2032) & (k units) Table 10. Global Cancer Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cancer Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cancer Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Cancer Vaccines Price by Type (2027-2032) & (US$/unit) Table 14. North America Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 15. North America Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 17. Europe Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 21. Latin America Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cancer Vaccines Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Cancer Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Cancer Vaccines Industry Trends Table 25. Cancer Vaccines Industry Drivers Table 26. Cancer Vaccines Industry Opportunities and Challenges Table 27. Cancer Vaccines Industry Restraints Table 28. Global Cancer Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cancer Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Cancer Vaccines Sales by Company (2021-2026) & (k units) Table 31. Global Cancer Vaccines Sales Share by Company (2021-2026) Table 32. Global Cancer Vaccines Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Cancer Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cancer Vaccines Major Company Production Sites and Headquarters Table 35. Global Cancer Vaccines Company, Product Type & Application Table 36. Global Cancer Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cancer Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cancer Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cancer Vaccines Sales by Region (2021-2026) & (k units) Table 41. Global Cancer Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cancer Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cancer Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Cancer Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Cancer Vaccines Sales by Region (2027-2032) & (k units) Table 46. Global Cancer Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cancer Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cancer Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Cancer Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Cancer Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 52. Global Cancer Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cancer Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Cancer Vaccines Price by Application (2021-2026) & (US$/unit) Table 56. Global Cancer Vaccines Sales by Application (2027-2032) & (k units) Table 57. Global Cancer Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cancer Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cancer Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Cancer Vaccines Price by Application (2027-2032) & (US$/unit) Table 61. North America Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 62. North America Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 64. Europe Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 68. Latin America Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cancer Vaccines Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Cancer Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Merck Cancer Vaccines Product Portfolio Table 75. Merck Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Pfizer Cancer Vaccines Product Portfolio Table 80. Pfizer Recent Development Table 81. Glaxosmithkline Company Information Table 82. Glaxosmithkline Business Overview Table 83. Glaxosmithkline Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Glaxosmithkline Cancer Vaccines Product Portfolio Table 85. Glaxosmithkline Recent Development Table 86. Serum Institute of India Company Information Table 87. Serum Institute of India Business Overview Table 88. Serum Institute of India Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Serum Institute of India Cancer Vaccines Product Portfolio Table 90. Serum Institute of India Recent Development Table 91. Sanpower Group Company Information Table 92. Sanpower Group Business Overview Table 93. Sanpower Group Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Sanpower Group Cancer Vaccines Product Portfolio Table 95. Sanpower Group Recent Development Table 96. Sanofi Pasteur Company Information Table 97. Sanofi Pasteur Business Overview Table 98. Sanofi Pasteur Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Sanofi Pasteur Cancer Vaccines Product Portfolio Table 100. Sanofi Pasteur Recent Development Table 101. CSL Limited Company Information Table 102. CSL Limited Business Overview Table 103. CSL Limited Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. CSL Limited Cancer Vaccines Product Portfolio Table 105. CSL Limited Recent Development Table 106. Astellas Pharma Company Information Table 107. Astellas Pharma Business Overview Table 108. Astellas Pharma Cancer Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Astellas Pharma Cancer Vaccines Product Portfolio Table 110. Astellas Pharma Recent Development Table 111. North America Cancer Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 112. North America Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 113. North America Cancer Vaccines Sales Market Share by Country (2021-2026) Table 114. North America Cancer Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 115. North America Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 116. North America Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Cancer Vaccines Market Share by Country (2021-2026) Table 119. North America Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 121. Europe Cancer Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. Europe Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 123. Europe Cancer Vaccines Sales Market Share by Country (2021-2026) Table 124. Europe Cancer Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 125. Europe Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Cancer Vaccines Market Share by Country (2021-2026) Table 129. Europe Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Cancer Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 133. Asia-Pacific Cancer Vaccines Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Cancer Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 135. Asia-Pacific Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Cancer Vaccines Market Share by Country (2021-2026) Table 139. Asia-Pacific Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 141. Latin America Cancer Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Latin America Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 143. Latin America Cancer Vaccines Sales Market Share by Country (2021-2026) Table 144. Latin America Cancer Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 145. Latin America Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Cancer Vaccines Market Share by Country (2021-2026) Table 149. Latin America Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Cancer Vaccines Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Cancer Vaccines Sales by Country (2021-2026) & (k units) Table 153. Middle East and Africa Cancer Vaccines Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Cancer Vaccines Sales Forecast by Country (2027-2032) & (k units) Table 155. Middle East and Africa Cancer Vaccines Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Cancer Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Cancer Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Cancer Vaccines Market Share by Country (2021-2026) Table 159. Middle East and Africa Cancer Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Cancer Vaccines Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Cancer Vaccines Distributors List Table 164. Cancer Vaccines Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Cancer Vaccines Image Figure 2. Global Cancer Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Vaccines Sales (2021-2032) & (k units) Figure 5. Preventive Cancer Vaccines Image Figure 6. Global Preventive Cancer Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 7. Therapeutic Cancer Vaccines Image Figure 8. Global Therapeutic Cancer Vaccines Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Cancer Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cancer Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cancer Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cancer Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cancer Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cervical Cancer Image Figure 24. Global Cervical Cancer Sales YoY Growth (2021-2032) & (k units) Figure 25. Prostate Cancer Image Figure 26. Global Prostate Cancer Sales YoY Growth (2021-2032) & (k units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 29. Global Cancer Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cancer Vaccines Market Share by Application 2025 VS 2032 Figure 31. North America Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. North America Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Europe Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Europe Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Latin America Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Cancer Vaccines Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Cancer Vaccines Sales Market Share in Value by Application in 2025 Figure 41. North America Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 42. North America Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. Europe Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Asia-Pacific Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Latin America Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cancer Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Middle East and Africa Cancer Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cancer Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Cancer Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Cancer Vaccines Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Cancer Vaccines Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Preventive Cancer Vaccines
  • Therapeutic Cancer Vaccines
Applications
  • Cervical Cancer
  • Prostate Cancer
  • Others
Companies covered
  • Merck
  • Pfizer
  • Glaxosmithkline
  • Serum Institute of India
  • Sanpower Group
  • Sanofi Pasteur
  • CSL Limited
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cancer Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cancer Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cancer Vaccines Market by Type
  6. 1.3.1 Preventive Cancer Vaccines
  7. 1.3.2 Therapeutic Cancer Vaccines
  8. 1.4 Global Cancer Vaccines Market Size by Type
  9. 1.4.1 Global Cancer Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cancer Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cancer Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cancer Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cancer Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cancer Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cancer Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cancer Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cancer Vaccines Industry Trends
  2. 2.2 Cancer Vaccines Industry Drivers
  3. 2.3 Cancer Vaccines Industry Opportunities and Challenges
  4. 2.4 Cancer Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cancer Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Cancer Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Cancer Vaccines Price (2021-2026)
  4. 3.4 Global Cancer Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cancer Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Cancer Vaccines Company, Product Type & Application
  7. 3.7 Global Cancer Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cancer Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cancer Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cancer Vaccines Tier 1, Tier 2, and Tier 3
4 Cancer Vaccines Regional Status and Outlook
  1. 4.1 Global Cancer Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cancer Vaccines Historic Market Size by Region
  3. 4.2.1 Global Cancer Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cancer Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cancer Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cancer Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Cancer Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cancer Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cancer Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cancer Vaccines by Application
  1. 5.1 Cancer Vaccines Market by Application
  2. 5.1.1 Cervical Cancer
  3. 5.1.2 Prostate Cancer
  4. 5.1.3 Others
  5. 5.2 Global Cancer Vaccines Market Size by Application
  6. 5.2.1 Global Cancer Vaccines Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cancer Vaccines Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cancer Vaccines Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cancer Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cancer Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cancer Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cancer Vaccines Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cancer Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Cancer Vaccines Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Cancer Vaccines Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 Glaxosmithkline
  14. 6.3.1 Glaxosmithkline Company Information
  15. 6.3.2 Glaxosmithkline Business Overview
  16. 6.3.3 Glaxosmithkline Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Glaxosmithkline Cancer Vaccines Product Portfolio
  18. 6.3.5 Glaxosmithkline Recent Developments
  19. 6.4 Serum Institute of India
  20. 6.4.1 Serum Institute of India Company Information
  21. 6.4.2 Serum Institute of India Business Overview
  22. 6.4.3 Serum Institute of India Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum Institute of India Cancer Vaccines Product Portfolio
  24. 6.4.5 Serum Institute of India Recent Developments
  25. 6.5 Sanpower Group
  26. 6.5.1 Sanpower Group Company Information
  27. 6.5.2 Sanpower Group Business Overview
  28. 6.5.3 Sanpower Group Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanpower Group Cancer Vaccines Product Portfolio
  30. 6.5.5 Sanpower Group Recent Developments
  31. 6.6 Sanofi Pasteur
  32. 6.6.1 Sanofi Pasteur Company Information
  33. 6.6.2 Sanofi Pasteur Business Overview
  34. 6.6.3 Sanofi Pasteur Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sanofi Pasteur Cancer Vaccines Product Portfolio
  36. 6.6.5 Sanofi Pasteur Recent Developments
  37. 6.7 CSL Limited
  38. 6.7.1 CSL Limited Company Information
  39. 6.7.2 CSL Limited Business Overview
  40. 6.7.3 CSL Limited Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 CSL Limited Cancer Vaccines Product Portfolio
  42. 6.7.5 CSL Limited Recent Developments
  43. 6.8 Astellas Pharma
  44. 6.8.1 Astellas Pharma Company Information
  45. 6.8.2 Astellas Pharma Business Overview
  46. 6.8.3 Astellas Pharma Cancer Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Astellas Pharma Cancer Vaccines Product Portfolio
  48. 6.8.5 Astellas Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Cancer Vaccines Sales by Country
  2. 7.1.1 North America Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cancer Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cancer Vaccines Market Size by Country
  6. 7.2.1 North America Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cancer Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Cancer Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cancer Vaccines Sales by Country
  2. 8.1.1 Europe Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cancer Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cancer Vaccines Market Size by Country
  6. 8.2.1 Europe Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cancer Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cancer Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cancer Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cancer Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cancer Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cancer Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cancer Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cancer Vaccines Sales by Country
  2. 10.1.1 South America Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cancer Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cancer Vaccines Market Size by Country
  6. 10.2.1 South America Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cancer Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Cancer Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cancer Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Cancer Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cancer Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cancer Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cancer Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Cancer Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cancer Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cancer Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cancer Vaccines Value Chain Analysis
  2. 12.1.1 Cancer Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cancer Vaccines Production Mode & Process
  7. 12.2 Cancer Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cancer Vaccines Distributors
  10. 12.2.3 Cancer Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst